Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-19-008329
Filing Date
2019-04-30
Accepted
2019-04-30 16:24:54
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dffn20190429_defa14a.htm DEFA14A 19242
2 a1.jpg GRAPHIC 112188
3 a2.jpg GRAPHIC 165973
4 a3.jpg GRAPHIC 45525
5 a4.jpg GRAPHIC 13615
  Complete submission text file 0001437749-19-008329.txt   485338
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37942 | Film No.: 19782131
SIC: 2834 Pharmaceutical Preparations